WallStSmart

DoorDash, Inc. Class A Common Stock (DASH)vsMedirom Healthcare Technologies Inc (MRM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

DoorDash, Inc. Class A Common Stock generates 70% more annual revenue ($13.72B vs $8.07B). DASH leads profitability with a 6.8% profit margin vs 0.5%. MRM trades at a lower P/E of 3.0x. DASH earns a higher WallStSmart Score of 59/100 (C).

DASH

Buy

59

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 4.0Quality: 7.0
Piotroski: 5/9Altman Z: 1.94

MRM

Hold

39

out of 100

Grade: F

Growth: 4.0Profit: 4.5Value: 6.7Quality: 3.0
Piotroski: 4/9Altman Z: 0.03
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DASHUndervalued (+3.0%)

Margin of Safety

+3.0%

Fair Value

$180.89

Current Price

$168.65

$12.24 discount

UndervaluedFair: $180.89Overvalued

Intrinsic value data unavailable for MRM.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DASH3 strengths · Avg: 9.0/10
Revenue GrowthGrowth
37.7%10/10

Revenue surging 37.7% year-over-year

Market CapQuality
$73.49B9/10

Large-cap with strong market position

EPS GrowthGrowth
47.7%8/10

Earnings expanding 47.7% YoY

MRM3 strengths · Avg: 9.3/10
P/E RatioValuation
3.0x10/10

Attractively priced relative to earnings

Return on EquityProfitability
53.2%10/10

Every $100 of equity generates 53 in profit

EPS GrowthGrowth
27.8%8/10

Earnings expanding 27.8% YoY

Areas to Watch

DASH4 concerns · Avg: 3.3/10
PEG RatioValuation
1.724/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.944/10

Grey zone — moderate risk

Profit MarginProfitability
6.8%3/10

6.8% margin — thin

P/E RatioValuation
79.5x2/10

Premium valuation, high expectations priced in

MRM4 concerns · Avg: 2.5/10
Market CapQuality
$9.17M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.5%3/10

0.5% margin — thin

Revenue GrowthGrowth
-6.7%2/10

Revenue declined 6.7%

Free Cash FlowQuality
$-2.48M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : DASH

The strongest argument for DASH centers on Revenue Growth, Market Cap, EPS Growth. Revenue growth of 37.7% demonstrates continued momentum.

Bull Case : MRM

The strongest argument for MRM centers on P/E Ratio, Return on Equity, EPS Growth.

Bear Case : DASH

The primary concerns for DASH are PEG Ratio, Altman Z-Score, Profit Margin. A P/E of 79.5x leaves little room for execution misses.

Bear Case : MRM

The primary concerns for MRM are Market Cap, Profit Margin, Revenue Growth. Debt-to-equity of 8.84 is elevated, increasing financial risk. Thin 0.5% margins leave little buffer for downturns.

Key Dynamics to Monitor

DASH profiles as a hypergrowth stock while MRM is a value play — different risk/reward profiles.

DASH carries more volatility with a beta of 1.93 — expect wider price swings.

DASH is growing revenue faster at 37.7% — sustainability is the question.

DASH generates stronger free cash flow (254M), providing more financial flexibility.

Bottom Line

DASH scores higher overall (59/100 vs 39/100) and 37.7% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

DoorDash, Inc. Class A Common Stock

CONSUMER CYCLICAL · INTERNET RETAIL · USA

DoorDash, Inc. operates a logistics platform that connects merchants, consumers, and merchants in the United States and internationally. The company is headquartered in San Francisco, California.

Visit Website →

Medirom Healthcare Technologies Inc

CONSUMER CYCLICAL · PERSONAL SERVICES · USA

MEDIROM Healthcare Technologies Inc. provides comprehensive healthcare services in Japan. The company is headquartered in Tokyo, Japan.

Visit Website →

Want to dig deeper into these stocks?